216 related articles for article (PubMed ID: 21036004)
1. [Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack].
Velayoudom-Cephise FL; Foucan L; Soudan B; Cardot-Bauters C; Vantyghem MC; D'herbomez M; Tison-Muchery F; Wemeau JL
Presse Med; 2011 Feb; 40(2):e120-7. PubMed ID: 21036004
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
3. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
7. The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.
Raef H; Ingemansson S; Sobhi S; Sultan A; Ahmed M; Chaudhry M
J Endocrinol Invest; 2004 Oct; 27(9):807-12. PubMed ID: 15648543
[TBL] [Abstract][Full Text] [Related]
8. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
Walker MD; Saeed I; Lee JA; Zhang C; Hans D; Lang T; Silverberg SJ
Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperparathyroidism and vitamin D deficiency.
Vélayoudom-Céphise FL; Wémeau JL
Ann Endocrinol (Paris); 2015 May; 76(2):153-62. PubMed ID: 25916759
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
11. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
Viccica G; Cetani F; Vignali E; Miccoli M; Marcocci C
Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D status in primary hyperparathyroidism: a Southern European perspective.
Tassone F; Gianotti L; Baffoni C; Visconti G; Pellegrino M; Cassibba S; Croce CG; Magro G; Cesario F; Attanasio R; Borretta G
Clin Endocrinol (Oxf); 2013 Dec; 79(6):784-90. PubMed ID: 23521111
[TBL] [Abstract][Full Text] [Related]
13. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
Shah VN; Shah CS; Bhadada SK; Rao DS
Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of primary hyperparathyroidism among patients with low bone mass.
Misiorowski W; Zgliczyński W
Adv Med Sci; 2012; 57(2):308-13. PubMed ID: 23314564
[TBL] [Abstract][Full Text] [Related]
15. Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism.
Cong E; Walker MD; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3452-9. PubMed ID: 26120793
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D treatment in primary hyperparathyroidism.
Rolighed L; Bollerslev J; Mosekilde L
Curr Drug Saf; 2011 Apr; 6(2):100-7. PubMed ID: 21524245
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of primary hyperparathyroidism from western India: a single center experience.
Gopal RA; Acharya SV; Bandgar T; Menon PS; Dalvi AN; Shah NS
J Postgrad Med; 2010; 56(2):79-84. PubMed ID: 20622385
[TBL] [Abstract][Full Text] [Related]
18. Osteopenia and vitamin D deficiency in children with sickle cell disease.
Chapelon E; Garabedian M; Brousse V; Souberbielle JC; Bresson JL; de Montalembert M
Eur J Haematol; 2009 Dec; 83(6):572-8. PubMed ID: 19682065
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.
Gianotti L; Tassone F; Cesario F; Pia A; Razzore P; Magro G; Piovesan A; Borretta G
J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
